Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. CRON
stocks logo

CRON

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
41.31M
+36.45%
0.010
-90.92%
47.66M
+47.91%
0.020
-0.08%
47.05M
+40.51%
0.020
-119.94%
Estimates Revision
The market is revising Upward the revenue expectations for Cronos Group Inc. (CRON) for FY2025, with the revenue forecasts being adjusted by 0.34% over the past three months. During the same period, the stock price has changed by 29.25%.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.34%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-247.06%
In Past 3 Month
Stock Price
Go Up
up Image
+29.25%
In Past 3 Month

Valuation Metrics

The current forward P/E ratio for Cronos Group Inc (CRON.O) is 40.10, compared to its 5-year average forward P/E of 374.67. For a more detailed relative valuation and DCF analysis to assess Cronos Group Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
374.67
Current PE
40.10
Overvalued PE
1589.34
Undervalued PE
-840.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-1.96
Current EV/EBITDA
10.34
Overvalued EV/EBITDA
8.77
Undervalued EV/EBITDA
-12.69

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
13.10
Current PS
5.56
Overvalued PS
25.38
Undervalued PS
0.82
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

CRON News & Events

Events Timeline

(ET)
2025-12-12
16:10:00
New
S&P 500 Pulls Back as Tech Stocks Sell Off
select
2025-12-12
15:40:00
U.S. Government Plans to Reclassify Cannabis to Schedule III
select
2025-12-12
14:40:00
Trump Pushes to Loosen Marijuana Restrictions, Benefiting Related Companies
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
8.0
12-07Barron's
Health Trends Won't Deter This Stock Offering a 7% Dividend Yield
  • Stock Performance: Altria's stock faces several challenges but maintains a stable performance.
  • Dividend Yield: The company offers a substantial 7% yield, which can mitigate some of its issues.
[object Object]
Preview
8.0
11-27TipRanks
Cannabis Stocks Surge as U.S. Medicare Weighs Coverage Options for TLRY, CGC, CRON

  • Medicare Coverage for CBD: U.S. Medicare is considering covering CBD treatments for certain patients, potentially boosting the cannabis industry as shares of leading companies rise by up to 4%.

  • Focus on Cancer and Palliative Care: The initiative primarily targets seniors undergoing cancer treatments or palliative care, marking a significant step for cannabis acceptance in medical settings.

  • Advocacy and Political Support: Payments financier Howard Kessler has engaged with Health and Human Services Secretary Robert F. Kennedy Jr. regarding expanded cannabis access, following previous support from President Trump.

  • Market Performance and Analyst Ratings: Cannabis stocks have struggled recently, with many trading as penny stocks; Tilray, for instance, has a Moderate Buy rating from analysts, suggesting a potential upside of over 92%.

[object Object]
Preview
2.0
11-14Benzinga
4 Cannabis Stocks Experience Momentum Gains Despite Congress Reinstating Restrictions on Certain THC Products in Spending Bill

  • Cannabis Stocks Momentum: Four cannabis stocks—Tilray Brands, Cronos Group, Organigram Global, and SNDL—are showing strong technical momentum despite new regulatory challenges from Congress that could impact the hemp-derived THC market.

  • Legislative Impact: A provision in a recent government funding bill threatens to re-criminalize many hemp-derived products, which could significantly disrupt the market and affect companies like Tilray that rely on these products for U.S. market entry.

  • Stock Performance Overview: The stocks have varying momentum rankings and performance metrics, with Tilray showing a strong long-term trend but weaker short-term performance, while SNDL has moderate growth despite overall weaker trends.

  • Industry Implications: The new legislation may benefit multi-state operators by reducing gray-market competition, but it poses risks for Canadian companies, particularly those like Tilray that are looking to expand into the U.S. market.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Cronos Group Inc (CRON) stock price today?

The current price of CRON is 3.27 USD — it has increased 14.74 % in the last trading day.

arrow icon

What is Cronos Group Inc (CRON)'s business?

Cronos Group Inc. is a global cannabinoid company engaged in building disruptive intellectual property by advancing cannabis research, technology and product development. The Company’s diverse international brand portfolio includes Spinach, PEACE NATURALS and Lord Jones. Spinach is a mainstream adult-use cannabis brand with a portfolio that includes cannabinoid products in a wide range of formats, including dried flower, pre-rolls, vaporizers, edibles and tinctures. Lord Jones is a premium adult-use cannabis brand. The Lord Jones brand portfolio includes cannabis products in the pre-roll, vaporizer and edible categories. Lord Jones Ice Water Hash Fusions pre-rolls feature flower and terpene-rich ice water hash and are fitted with a branded ceramic tip. PEACE NATURALS is a global medical brand engaged in producing cannabis products. The Company distributes products under the PEACE NATURALS brand for the Canadian market and the Israeli, German, and United Kingdom medical markets.

arrow icon

What is the price predicton of CRON Stock?

Wall Street analysts forecast CRON stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CRON is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Cronos Group Inc (CRON)'s revenue for the last quarter?

Cronos Group Inc revenue for the last quarter amounts to 36.34M USD, increased 6.06 % YoY.

arrow icon

What is Cronos Group Inc (CRON)'s earnings per share (EPS) for the last quarter?

Cronos Group Inc. EPS for the last quarter amounts to 0.07 USD, increased 250.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for Cronos Group Inc (CRON)'s fundamentals?

The market is revising Upward the revenue expectations for Cronos Group Inc. (CRON) for FY2025, with the revenue forecasts being adjusted by 0.34% over the past three months. During the same period, the stock price has changed by 29.25%.
arrow icon

How many employees does Cronos Group Inc (CRON). have?

Cronos Group Inc (CRON) has 356 emplpoyees as of December 13 2025.

arrow icon

What is Cronos Group Inc (CRON) market cap?

Today CRON has the market capitalization of 1.25B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free